Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Annals of Internal Medicine|April 1, 1996
Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarinJ R Leclerc, W H Geerts, L Desjardins, et al.
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
Chronic venous abnormalities in symptomatic and asymptomatic protein C deficiencyJ Emmerich, C Y Vossen, P W Callas, et al.
Journal of Thrombosis and Haemostasis : JTH|November 28, 2008
Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trialE Rey, P Garneau, M David, et al.
Thrombosis and Haemostasis|March 1, 1993
An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibitionC Demers, P Henderson, M A Blajchman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 2, 2018
A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third-generation B-domain-deleted recombinant factor VIIIE Dubé, A Bonnefoy, C Merlen, et al.
Kidney International|September 7, 2007
Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesisM Usatii, L Rousseau, C Demers, et al.
The New England Journal of Medicine|August 14, 1997
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study GroupM Cohen, C Demers, E P Gurfinkel, et al.
The American Journal of Cardiology|September 16, 1998
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary EventsM Cohen, C Demers, E P Gurfinkel, et al.
Biochemical Pharmacology|May 19, 2024
AMPA receptors play an important role in the biological consequences of spinal cord injury: Implications for AMPA receptor modulators for therapeutic benefitJeffrey M Witkin, Daniel P Radin, Sabhya Rana, et al.
Thrombosis and Haemostasis|November 1, 2001
Evidence of a founder effect for the protein C gene 3363 inserted C mutation in thrombophilic pedigrees of French originP Couture, E G Bovill, C Demers, et al.
Pageof 7